6CM
CLDI.WS
683 Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-599,702
| Closed | -$7.86K | – | 248 |
|
|
2024
Q3 | $7.86K | Hold |
599,702
| – | – | ﹤0.01% | 114 |
|
|
2024
Q2 | $25.2K | Sell |
599,702
-298
| -0% | -$13 | ﹤0.01% | 106 |
|
|
2024
Q1 | $31.2K | Hold |
600,000
| – | – | ﹤0.01% | 97 |
|
|
2023
Q4 | $30K | Hold |
600,000
| – | – | ﹤0.01% | 209 |
|
|
2023
Q3 | $132K | Hold |
600,000
| – | – | 0.01% | 89 |
|
|
2023
Q2 | $78K | Hold |
600,000
| – | – | 0.01% | 96 |
|
|
2023
Q1 | $24.6K | Hold |
600,000
| – | – | ﹤0.01% | 224 |
|
|
2022
Q4 | $30K | Hold |
600,000
| – | – | ﹤0.01% | 234 |
|
|
2022
Q3 | $33K | Hold |
600,000
| – | – | ﹤0.01% | 175 |
|
|
2022
Q2 | $54K | Hold |
600,000
| – | – | ﹤0.01% | 197 |
|
|
2022
Q1 | $216K | Buy |
600,000
+500,000
| +500% | +$180K | 0.01% | 255 |
|
|
2021
Q4 | $51K | Buy |
+100,000
| New | +$51K | ﹤0.01% | 302 |
|